SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: HeatherN who wrote (33711)4/28/1999 2:43:00 PM
From: MARK C.  Read Replies (1) of 90042
 
Heather I agree with you about celebrex and vioxx comparison. I was referring to the time frame of now till the split. Celebrex was first to market and those #'s will be great. Once Vioxx comes out it will likely catch up and exceed celebrex from what I am hearing. I should have been more specific. Yet the #'s will help boost PFE share price over the next 2 months. I also forgot to mention PFE has the best sales force in the industry. Thanks for making the point Heather. :-) MarkC
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext